Tirschwell & Loewy Has Trimmed By $1.68 Million Its Occidental Pete Cal (OXY) Position; Profile of 4 Analysts Covering Oramed Pharmaceuticals Inc. (ORMP)

February 15, 2018 - By Vivian Park

Among 4 analysts covering Oramed Pharmaceuticals (NASDAQ:ORMP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Oramed Pharmaceuticals had 9 analyst reports since August 14, 2015 according to SRatingsIntel. Rodman & Renshaw initiated Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) on Friday, October 2 with “Buy” rating. FBR Capital initiated the stock with “Outperform” rating in Thursday, November 19 report. The firm has “Buy” rating by B. Riley & Co given on Monday, December 11. The company was initiated on Thursday, October 1 by H.C. Wainwright. The stock of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has “Buy” rating given on Thursday, October 5 by H.C. Wainwright. The rating was maintained by H.C. Wainwright on Wednesday, November 22 with “Buy”. The firm has “Buy” rating by H.C. Wainwright given on Tuesday, December 1. On Friday, August 14 the stock rating was upgraded by Zacks to “Sell”. See Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) latest ratings:

11/12/2017 Broker: B. Riley & Co Rating: Buy New Target: $20 Maintain
11/12/2017 Broker: FBR Capital Rating: Buy New Target: $20.0
22/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $25.0 Maintain
05/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $25.0 Maintain

Tirschwell & Loewy Inc decreased Occidental Pete Corp Cal (OXY) stake by 81.25% reported in 2017Q3 SEC filing. Tirschwell & Loewy Inc sold 26,275 shares as Occidental Pete Corp Cal (OXY)’s stock declined 8.50%. The Tirschwell & Loewy Inc holds 6,064 shares with $389,000 value, down from 32,339 last quarter. Occidental Pete Corp Cal now has $52.40B valuation. The stock decreased 1.98% or $1.38 during the last trading session, reaching $68.47. About 1.10M shares traded. Occidental Petroleum Corporation (NYSE:OXY) has declined 18.97% since February 15, 2017 and is downtrending. It has underperformed by 35.67% the S&P500.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company has market cap of $110.51 million. The Company’s product portfolio includes ORMD-0801, an oral insulin capsule, which has completed Phase IIb clinical trials for the treatment of diabetes; and ORMD-0901, an analog for GLP-1 gastrointestinal hormone, which has completed Phase Ib clinical trials for the treatment of type 2 diabetes. It currently has negative earnings. The firm operates primarily in Israel.

Investors sentiment decreased to 2 in Q3 2017. Its down 4.00, from 6 in 2017Q2. It fall, as 2 investors sold Oramed Pharmaceuticals Inc. shares while 2 reduced holdings. 2 funds opened positions while 6 raised stakes. 255,973 shares or 20.44% less from 321,734 shares in 2017Q2 were reported. Jpmorgan Chase Co accumulated 0% or 885 shares. Jfs Wealth Advisors Llc owns 500 shares or 0% of their US portfolio. Renaissance holds 0% or 83,000 shares in its portfolio. Moreover, Morgan Stanley has 0% invested in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for 14,766 shares. Barclays Public Limited invested 0% in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP). Royal Bancorp Of Canada holds 0% or 500 shares. 393 are owned by Tower Ltd Llc (Trc). Glenmede Communications Na holds 0% or 20,000 shares. Group Incorporated One Trading L P holds 0% of its portfolio in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for 7,605 shares. Deutsche National Bank & Trust Ag holds 29,434 shares. Moreover, Pnc Fincl Ser has 0% invested in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for 21,200 shares. Moreover, State Bank Of Montreal Can has 0% invested in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) for 1,600 shares. Susquehanna Gp Llp invested 0% in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP). Natl Bank Of America De reported 1,117 shares. California-based Wells Fargo & Mn has invested 0% in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP).

The stock increased 1.05% or $0.08 during the last trading session, reaching $7.69. About 402 shares traded. Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) has risen 2.79% since February 15, 2017 and is uptrending. It has underperformed by 13.91% the S&P500.

Investors sentiment decreased to 0.89 in 2017 Q3. Its down 0.06, from 0.95 in 2017Q2. It fall, as 59 investors sold OXY shares while 338 reduced holdings. 89 funds opened positions while 264 raised stakes. 602.00 million shares or 0.86% less from 607.21 million shares in 2017Q2 were reported. Arizona State Retirement System holds 0.21% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY) for 276,449 shares. Thompson Siegel And Walmsley Limited Liability Corp owns 9,350 shares or 0.01% of their US portfolio. Reliance Tru Of Delaware, Delaware-based fund reported 5,909 shares. Anchor Advsrs Limited Liability Company invested in 0.95% or 411,051 shares. Perkins Coie Com owns 340 shares or 0.01% of their US portfolio. Moreover, Utd Capital Financial Advisers has 0.14% invested in Occidental Petroleum Corporation (NYSE:OXY) for 255,569 shares. Meiji Yasuda Asset Ltd reported 0.19% stake. Boulegeris Invs invested 0.42% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY). Delta Asset Management Limited Liability Com Tn stated it has 826 shares. Gamco Invsts Et Al holds 0.01% or 31,768 shares. Investment Centers Of America Inc holds 0.03% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY) for 5,824 shares. Factory Mutual Insurance Com invested in 0.27% or 390,000 shares. Barclays Public Ltd has 0.05% invested in Occidental Petroleum Corporation (NYSE:OXY) for 796,927 shares. Fort Washington Invest Advisors Inc Oh owns 114,837 shares. Oarsman Cap reported 6,301 shares or 0.17% of all its holdings.

Among 21 analysts covering Occidental Petroleum Corporation (NYSE:OXY), 4 have Buy rating, 1 Sell and 16 Hold. Therefore 19% are positive. Occidental Petroleum Corporation had 83 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, November 21 by Piper Jaffray. The firm has “Sector Perform” rating given on Friday, July 31 by RBC Capital Markets. UBS maintained the stock with “Neutral” rating in Thursday, August 4 report. The stock of Occidental Petroleum Corporation (NYSE:OXY) has “Hold” rating given on Friday, November 3 by Jefferies. The stock of Occidental Petroleum Corporation (NYSE:OXY) has “Underweight” rating given on Wednesday, October 11 by Barclays Capital. Mizuho maintained Occidental Petroleum Corporation (NYSE:OXY) rating on Tuesday, November 21. Mizuho has “Hold” rating and $71.0 target. The stock has “Hold” rating by Jefferies on Thursday, October 19. Piper Jaffray maintained Occidental Petroleum Corporation (NYSE:OXY) on Tuesday, January 23 with “Hold” rating. Mizuho downgraded Occidental Petroleum Corporation (NYSE:OXY) rating on Monday, February 13. Mizuho has “Neutral” rating and $70 target. The stock has “Hold” rating by BMO Capital Markets on Friday, May 5.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>